  | 
 
 
            
            
            | Recent Press 
              Releases > Plasmacluster Ions® Proven Effective Against 
              Airborne Highly Pathogenic H5N1 Avian Influenza | 
 
 
  | 
 
 
  | 
 
 
 
  | 
            
             June 6, 2005 | 
 
 
  | 
 
 
 
            
              
              Plasmacluster Ions®*1 Proven Effective 
                Against Airborne Highly Pathogenic H5N1 Avian Influenza
              
              
                
              A World First Among Air Purification Technologies*2 
                 
               | 
 
 
  | 
 
 
          
          
           
              
                
 
                  
                  
                  Sharp Corporation has demonstrated that Plasmacluster 
                    Ions reduce activity of the highly fatal and highly pathogenic 
                    airborne H5N1 avian influenza (“bird flu”) virus 
                    by 99%. This research was conducted in collaboration with 
                    Retroscreen Virology, Ltd., an organization which was established 
                    by one of the world’s leading authorities on virology, 
                    Professor John S. Oxford of the University of London School 
                    of Medicine & Dentistry, and which works in compliance 
                    with Good Laboratory Practice*3 (GLP). Among the diverse range 
                    of air purification technologies available, Plasmacluster 
                    Ions are the first in the world to have been proven effective 
                    against this virus. 
                     
                    Plasmacluster Ion technology was developed in 2000 and is 
                    an air purification technology that disables airborne microorganisms 
                    by releasing positive and negative ions into the air. In the 
                    five years since its development, Sharp has been working together 
                    with academic research organizations around the world based 
                    on a “collaborative research approach to product marketing*4” 
                    and has demonstrated that Plasmacluster Ions are effective 
                    against a total of 26 kinds of harmful airborne substances, 
                    including bacteria, mold fungi, viruses and allergens. In 
                    addition, in November 2004, the mechanism by which Plasmacluster 
                    Ions cause cell death was explained: they damage the proteins 
                    on the cell membrane surface of bacteria. It has now been 
                    proven scientifically that they have the potential to be effective 
                    against a broad array of harmful airborne substances that 
                    have proteins on their cell surfaces. 
                     
                    The type of avian influenza virus for which effectiveness 
                    has most recently been confirmed is the highly pathogenic 
                    H5N1 avian influenza virus, which has in fact taken a toll 
                    on human life. This research finding confirms that Plasmacluster 
                    Ions are effective against newly emerging viruses and has 
                    further expanded the fields in which Plasmacluster Ions demonstrate 
                    efficacy. 
                     
                      
                      
                     
                     
                    
                       
                        | *1 | 
                        Plasmacluster and Plasmacluster Ions 
                          are trademarks of Sharp Corporation. | 
                       
                       
                        | *2 | 
                         As of June 6, 2005 | 
                       
                       
                        | *3 | 
                        In the OECD (Organization for Economic 
                          Co-operation and Development), Good Laboratory Practice 
                          is a set of standards intended to ensure the reliability 
                          of test results by reviewing operation management, test 
                          equipment, test design, internal audit controls, quality 
                          assurance systems, test results, etc., at all test facilities. 
                          Re-certification is required every three years. | 
                       
                       
                        | *4 | 
                        The “collaborative research 
                          approach to product marketing” verifies the effectiveness 
                          of a technology based on scientific data developed in 
                          collaboration with leading-edge academic research institutions. 
                          New products are then brought to market based on the 
                          results. | 
                       
                       
                        | *5 | 
                        Canine kidney cells | 
                       
                     
                     
                     
                    Virus infection test using cultured cells 
                    A Plasmacluster Ion Generator was placed in a box with a volume 
                    of one (1) m3, and Plasmacluster Ions were generated (concentration: 
                    7000 ions/cm3). Then, aerosolized highly pathogenic avian 
                    influenza virus was sprayed into the box. Five minutes after 
                    the spraying was complete, the air in the box containing the 
                    airborne virus was sampled at 10-minute intervals. The virus 
                    was then extracted and injected into cell cultures. Changes 
                    in the cells were then observed over a four-day period. 
                     
                    Four days after injection, the cells injected with the virus 
                    that had not been exposed to Plasmacluster Ions were deformed 
                    and damaged. In contrast, cells injected with the virus that 
                    had been exposed to Plasmacluster Ions retained their normal 
                    condition with almost no change in evidence.  
                     
                    From this, it was confirmed that Plasmacluster Ions can reduce 
                    the activity of the virus by 99%. (The TCID50 [Tissue Culture 
                    Infectious Dose 50%] assay, which is widely used in the field 
                    of virology, was used to evaluate the test results.) 
                     
                     
                    
                       
                        Observation 
                            photographs of cells (MDCK cells) injected with virus 
                            samples  | 
                       
                       
                        Cells injected with 
                            virus sample  
                            not exposed to Plasmacluster Ions  | 
                          | 
                        Cells injected with 
                            virus sample exposed to Plasmacluster Ions  | 
                       
                     
                      
                     
                     
                    Analysis of cell antibodies with the Fluorescent Antibody 
                    Technique 
                    Both the virus samples, those exposed to Plasmacluster Ions 
                    and those not, were injected into cells and the cell reaction 
                    to the viral infection was evaluated. This examination was 
                    conducted using the Fluorescent Antibody Technique, a standard 
                    method in the field of virus research. The technique involves 
                    dyeing cells with fluorescence to identify whether or not 
                    the cell is infected; if the cell has been infected by the 
                    virus, it will radiate. 
                     
                    In cells injected with the virus “not exposed” 
                    to Plasmacluster Ions, fluorescent coloring indicative of 
                    a viral infection was present. And, in contrast, the coloring 
                    was not present in cells injected with the virus “exposed” 
                    to Plasmacluster Ions. From this analysis, the virus sampled 
                    in the presence of Plasmacluster Ions was verified to have 
                    lost its capacity for infection.  
                       
                    
                       
                        Fluorescent 
                            coloring photograph of 
                            cells (MDCK cells) injected with virus samples  | 
                       
                       
                        Injected with a virus 
                            sample 
                            not exposed to Plasmacluster Ions  | 
                          | 
                        Injected with a virus 
                            sample exposed to Plasmacluster Ions  | 
                       
                     
                    
                      
                     
                     
                    About Highly Pathogenic Avian Influenza (“Bird 
                    Flu”) 
                    Various types of influenza virus are classified according 
                    to two types of “spikes” on the virus surface 
                    (H: hemagglutinin and N: neuraminidase), and among these, 
                    viruses that infect poultry and cause illness and death are 
                    well known, such as H5N1, H7N7, H9N2, etc.  
                     
                    In contrast to mildly pathogenic influenza viruses which infect 
                    and proliferate only in the respiratory organs and intestinal 
                    tract and whose symptoms remain relatively minor, highly pathogenic 
                    influenza viruses infect and multiply throughout the entire 
                    body. In poultry, the mortality rate approaches 100%. 
                     
                    Since 1997, avian influenza has taken a tremendous toll on 
                    poultry in Hong Kong, the Netherlands, Vietnam, Cambodia, 
                    Thailand, Korea and Japan. Furthermore, in Vietnam, Cambodia 
                    and Thailand, its transmission to humans, who were previously 
                    not considered susceptible, has been confirmed with the occurrence 
                    of 97 patient cases and 53 deaths*6. This current 
                    research proves the efficacy of Plasmacluster Ions on the 
                    highly pathogenic H5N1 avian influenza virus, which has in 
                    fact taken a toll on human life. 
                     
                    
                       
                        | *6 | 
                        As of May 19, 2005; according to 
                          a news release from the World Health Organization (WHO). | 
                       
                     
                     
                     
                    Overview of Plasmacluster Ion Technology 
                    A plasma discharge generates positive ions (H+) 
                    and negative ions (O2–) from water 
                    vapor in the air. These ions have the property of clustering 
                    around microparticles, and thus, they surround harmful substances 
                    such as airborne mold, viruses and allergens. At that point, 
                    a chemical reaction occurs on the cell membrane surface, and 
                    they are transformed into OH radicals, a powerfully active 
                    but unstable material, which robs the harmful substance of 
                    a hydrogen atom (H). As a result, they are inactivated by 
                    severing the protein on the cell membrane, opening holes. 
                    The OH radicals instantly bond with the removed hydrogen (H), 
                    forming water vapor (H2O), and return to the air. 
                     
                    
                       
                        | 1) | 
                        The Plasmacluster Ions are the same positive 
                          and negative ions found in abundance in nature, for 
                          example, in woods and forests. They turn into OH radicals 
                          only on the surface of harmful substances to inactivate 
                          them, so they are completely harmless to the human body. 
                          The amount of ozone generated is less than 0.01 ppm, 
                          significantly below the 0.05-ppm value set as the standard 
                          for industry and for electrical equipment.  | 
                       
                     
                     
                    
                       
                        | 2) | 
                        Compared to passive air cleaning systems 
                          that trap airborne contaminants by using a fan to draw 
                          air through a filter, air purification systems based 
                          on Plasmacluster Ions effectively eliminate bacteria 
                          by working directly on the air contained in the entire 
                          room. | 
                       
                      
                     
                    
                       
                        | 3) | 
                        The Plasmacluster Ion Generator never 
                          loses its effectiveness by becoming dirty and never 
                          needs replacing like filters. It consumes a miniscule 
                          amount of electricity (0.5 W). Annual electricity costs 
                          for continuous use are around ¥100.  | 
                       
                      
                      
                     
                    Efficacy of Plasmacluster Ions on Various Pathogens Confirmed 
                    Through Collaborative Research  
                    
                       
                        Target Substance  | 
                        Species  | 
                        Testing & Verification Organization  | 
                        Date of Announcement  | 
                       
                       
                        | Fungi | 
                        Cladosporium (black mold, mildew) | 
                        Ishikawa Health Service Association | 
                        September 2000 | 
                       
                       
                        | Universitäklinikums Lübeck University Clinic 
                          (Germany) (proliferation control effect) | 
                        February 2002 | 
                       
                       
                        | CT&T (Professor Gerhard Artmann, Aachen University 
                          of Applied Sciences) | 
                        November 2004 | 
                       
                       
                        | Penicillium, Aspergillus | 
                        Universitäklinikums Lübeck University Clinic 
                          (Germany) (proliferation control effect) | 
                        February 2002 | 
                       
                       
                        | Aspergillus, Penicillium (two species), Stachybotrys, 
                          Alternaria, Mucorales | 
                        CT&T (Professor Gerhard Artmann, Aachen University 
                          of Applied Sciences) | 
                        November 2004 | 
                       
                       
                        | Bacteria | 
                        Coliform bacteria (E. coli) | 
                        Ishikawa Health Service Association | 
                        September 2000 | 
                       
                       
                        | E. coli, Staphylococcus (aureus), Candida | 
                        Shanghai Municipal Center for Disease Control and 
                          Prevention, China | 
                        October 2001 | 
                       
                       
                        | Bacillus subtilis | 
                        Kitasato Research Center of Environmental Sciences | 
                        September 2002 | 
                       
                       
                        | CT&T (Professor Gerhard Artmann, Aachen University 
                          of Applied Sciences) | 
                        November 2004 | 
                       
                       
                        | MRSA (methicillin-resistant Staphylococcus 
                          aureus) | 
                        Kitasato Research Center of Environmental Sciences | 
                        September 2002 | 
                       
                       
                        | Kitasato Institute Medical Center Hospital | 
                        February 2004 | 
                       
                       
                        | Pseudomonas, Enterococcus, Staphylococcus | 
                        Universitäklinikums Lübeck University Clinic 
                          (Germany) | 
                        February 2002 | 
                       
                       
                        | Enterococcus, Staphylococcus, Sarcina, Micrococcus | 
                        CT&T (Professor Gerhard Artmann, Aachen University 
                          of Applied Sciences) | 
                        November 2004 | 
                       
                       
                        | Allergens | 
                        Mite allergen (dust from dead mite bodies and feces), 
                          pollen | 
                        Graduate School of Advanced Sciences of Matter, Hiroshima 
                          University | 
                        September 2003 | 
                       
                       
                        | Airborne allergens | 
                        Asthma Society of Canada | 
                        April 2004 | 
                       
                       
                        | Viruses | 
                        H1N1 influenza virus | 
                        Kitasato Research Center of Environmental Sciences | 
                        September 2002 | 
                       
                       
                        | Seoul University, Korea | 
                        September 2003 | 
                       
                       
                        | Shanghai Municipal Center for Disease Control and 
                          Prevention, China | 
                        December 2003 | 
                       
                       
                        | Kitasato Institute Medical Center Hospital | 
                        February 2004 | 
                       
                       
                        | H5N1 avian influenza virus | 
                        Retroscreen Virology, Ltd, London, U.K. | 
                        May 2005 | 
                       
                       
                        | Coxsackie virus (summer colds) | 
                        Kitasato Research Center of Environmental Sciences | 
                        September 2002 | 
                       
                       
                        | Polio virus | 
                        Kitasato Research Center of Environmental Sciences | 
                        September 2002 | 
                       
                       
                        | Corona virus | 
                        Kitasato Institute Medical Center Hospital | 
                        July 2004 | 
                       
                     
                     
                     
                    Profile of Professor John S. Oxford  
                    
                       
                        | • | 
                        World authority on virology | 
                       
                       
                        | • | 
                        Professor, Institute of Cell and Molecular 
                          Science at St. Bartholomew's and The Royal London Hospital, 
                          Queen Mary's School of Medicine and Dentistry, London, 
                          U.K. | 
                       
                      
                        | • | 
                        Founder and Scientific Director, Retroscreen 
                          Virology Ltd., | 
                       
                     
                     
                    Expertise 
                    Virology 
                     
                    Publications 
                    
                    
                       
                        | • | 
                        Published over 250 scientific papers | 
                       
                       
                        | • | 
                        Co-authored three standard texts: 
                          1) Influenza, the Viruses and the Disease 
                          2) Human Virology, a Text for Students of Medicine, 
                          Dentistry and Microbiology 
                          3) Conquest of Viral Diseases | 
                       
                     
                     
                     
                    Other Professional Activities  
                    
                    
                       
                        | • | 
                        Appeared on numerous radio and TV programs 
                          (BBC, National Geographic, etc.) | 
                       
                       
                        | • | 
                        Served as chairman of numerous international 
                          scientific and academic conferences | 
                       
                     
                     
                    Conferences where Prof. Oxford will serve as Chairman in the 
                    near future:  
                    
                       
                        | 1) | 
                        Second European Conference on Influenza, 
                          September 2005, Malta | 
                       
                       
                        | 2) | 
                        Optimizing Antiviral Drug Therapy Symposium, 
                          October 2005, Berlin | 
                       
                      
                        | 3) | 
                        The Central Role of Antivirals for the 
                          First Pandemic of the 21st Century, January 2006, London | 
                       
                     
                     
                     
                    About the University of London 
                    Established in 1836 as England’s national university, 
                    the University of London consists of 19 colleges with a total 
                    of 115,000 students, one of the largest student bodies in 
                    the world. 
                     
                    Queen Mary is one of the largest multi-faculty colleges of 
                    the University of London. Queen Mary merged with two distinguished 
                    medical colleges, St Bartholomew’s Hospital Medical 
                    College, established in 1843, and the London Hospital Medical 
                    College, England's oldest medical school, founded in 1785, 
                    to form the School of Medicine & Dentistry. With nearly 
                    8,800 students, the School provides education in a wide range 
                    of fields in addition to medicine and dentistry, including 
                    biology, chemistry, physics, electrical engineering, computer 
                    science, law, literature, and political science. 
                     
                    Dinstinguished Graduates 
                    Alexander Graham Bell, Hirofumi Ito (first prime minister 
                    of Japan), John F. Kennedy, Mahatma Gandhi, H.G. Wells, Arthur 
                    C. Clarke; seven Nobel Prize winners. 
                     
                     
                    About Retroscreen Virology, Ltd. 
                    Founded in 1989 by Professor John Oxford, Retroscreen Virology 
                    Ltd. is a recognized leader in the research and testing of 
                    antiviral compounds and vaccines. In carrying out safety tests 
                    of chemical substances, the company works to extremely high 
                    standards in compliance with the principles of Good Laboratory 
                    Practice (GLP), an international management standard for maintaining 
                    high reliability, and has obtained accreditation under the 
                    quality control management standard ISO 9001. 
                     
                     
                    Reference 
                     
                    Mechanism of Plasmacluster Ion for Inactivating Harmful Substances 
                     
                    Mechanism for Inactivating Airborne Fungi 
                    The positive (H+) and negative (O2-) 
                    ions cluster together on the surface of airborne fungi, causing 
                    a chemical reaction that results in the creation of highly 
                    reactive OH groups called hydroxyl radicals (•OH). The 
                    hydroxyl radical will take a hydrogen molecule from the cell 
                    wall of an airborne fungi particle. Inhibits mold infestation 
                    as well as controls musty and household odors (caused in large 
                    part by mold fungi) as they occur.  
                      
                    Mechanism for Inactivating Airborne Virus 
                    The positive (H+) and negative (O2-) 
                    ions surround the hemagglutinin (surface proteins that form 
                    on organisms and trigger infections) and change into highly 
                    reactive OH groups called hydroxyl radicals (•OH). These 
                    take a hydrogen molecule from the hemagglutinin and change 
                    into water (H2O). The ions destroy the virus surface 
                    structure, for example its envelopes and spikes, on a molecular 
                    level. As a result, the virus cannot infect even if it enters 
                    the body.
   
                    Mechanism for Deactivating Airborne Allergens 
                    The positive (H+) and negative (O2-) 
                    ions surround the airborne allergen and change into highly 
                    reactive hydroxyl radicals (•OH). The hydroxyls then 
                    deactivate the molecules of the IgE antibody binding site 
                    of the allergen. No allergic symptoms occur even if allergens 
                    enter the body.  
                      
                    
  | 
 
 
 | 
 
 
 
  | 
 
 
 
  
The following information is true and accurate at the time of publication. Manufacture, 
sale, price and specifications of products may be subjected to change.  
 
  | 
 
            
 
              
              
                
 
                  
| Press contact: | 
Sharp Corporation 
                    Public Relations Division 
                    Osaka: 81-6-6621-1272 Tokyo: 81-3-3260-1870 | 
 
              
 
 | 
 
 
 
|  
 | 
 
 
            
            
            | Recent Press 
              Releases > Plasmacluster Ions® Proven Effective 
              Against Airborne Highly Pathogenic H5N1 Avian Influenza | 
 
 
  | 
 
 
 |